Anticipating the interaction between technology and morality: A scenario study of experimenting with humans in bionanotechnology

Studies in Ethics, Law, and Technology

Volumn 4, Issue 2, 2010, Pages

  Boenink, Marianne ^a   Swierstra, Tsjalling ^b   Stemerding, Dirk ^c  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Rathenau Institute KNAW   (Netherlands)

Author keywords

bionanotechnology; ethics; experimenting with human beings; future; morality; scenario; technology

Indexed keywords

EID: 77956364034     PISSN: None     EISSN: 19416008     Source Type: Journal    
DOI: 10.2202/1941-6008.1098     Document Type: Article

References (52)

1. Boenink, Marianne (2009): 'Tensions and opportunities in convergence: Shifting concepts of disease in emerging molecular medicine', NanoEthics 3, 243-255.
2. Brown, N., Rappert, B. and Webster, A. (eds.) (2000): Contested Futures. A sociology of prospective techno-science. Aldershot: Ashgate.
3. Burg, Wybren van den (2003): 'Dynamic ethics', The Journal of Value Inquiry 27, 13-34.
4. Collingridge, D. (1980): The Social Control of Technology. New York: St. Martin's Press.
5. CTMM Working Group (2006): Business Plan Center for Translational Molecular Medicine. Den Haag: CTMM.
6. Decker, Michael (2004): 'The role of ethics in interdisciplinary technology assessment', Poiesis & Praxis 2, 139-156.
7. Dewey, John (1902a): 'The Evolutionary method as Applied to Morality I: Its Scientific Necessity', The Philosophical Review 11 (2), 107-124.
8. Dewey, John (1902b): 'The Evolutionary method as Applied to Morality II: Its Significance for Conduct', The Philosophical Review 11 (4), 353-371.
9. Dute, J.C.J. (2003): 'Toepassing van de genetica in het kader van wetenschappelijk onderzoek', in: Toepassing van de genetica in de gezondheidszorg: Gevolgen van de ontwikkelingen voor de huidige wet- en regelgeving. Den Haag: Commissie Genetica ZonMW.
10. Elzen B., Hofman, P. and Geels, F. (2002): Sociotechnical Scenarios-A new methodology to explore technological transitions. Enschede: University of Twente.
11. European Group on Ethics (2007): Opinion on the ethical aspects of nanomedicine. Brussels: European Group on Ethics in Science and New Technologies to the European Commission.
12. Fortina, P. et al. (2005): 'Nanobiotechnology: the promise and reality of new approaches to molecular recognition', TRENDS in Biotechnology 23 (4), 168-173.
13. Gezondheidsraad (2006): Betekenis van nanotechnologieën voor de gezondheid. Den Haag: Gezondheidsraad.
14. Gouinlock, J. (1994): The moral writings of John Dewey (revised edition). Amherst: Prometheus.
15. Johnson, J. A. and Evans, W. E. (2002): 'Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity', TRENDS in Molecular Medicine 8 (6), 300-305.
16. Jotterand, F. de (ed.) (2008): Emerging conceptual, ethical and policy issues in bionanotechnology. Dordrecht: Springer.
17. Jouvenel, Hugues de (2000): 'A Brief Methodological Guide to Scenario Building', Technological Forecasting and Social Change 65, 37-48.
18. Keulartz, J., Schermer, M., Korthals, M. and Swierstra, T. (2004): 'Ethics in a Technological Culture. A Programmatic Proposal for a Pragmatist Approach', Science, Technology and Human Values 29 (1), 3-29.
19. Klüver, L.K. et al. (2000), European Participatory Technology Assessment. Participatory Methods in Technology Assessment and Technology Decision- Making. Brussels: European Commission.
20. Malsch, N. H. (2005): Biomedical Nanotechnology. London: Taylor & Francis.
21. Merkerk, Rutger O. van, and Smits, Ruud E.H.M. (2008): 'Tailoring CTA for emerging technologies', Technological Forecasting and Social Change 75, 312-333.
22. Miller, G.M., and Brody, H. (2001): The Internal Morality of Medicine: an Evolutionary Perspective, Journal of Medicine and Philosophy, 26, 581-599.
23. Ministerie van Volksgezondheid, Welzijn en Sport (2002): Brief aan Voorzitter van de Tweede Kamer, January 17, 2002, available at: http://www.minvws.nl/kamerstukken/ibe/notitie-afnemen-lichaamsmateriaa l-vertraagd.asp, accessed January 14, 2008.
24. Nordmann, Alfred (2007): If and Then: A Critique of Speculative NanoEthics, Nanoethics 1 (1), 31-47.
25. Notten, Ph. Rotmans, W.F., J. van Asselt, M.B.A. and Rothman, D.S. (2003): An updated scenario typology, Futures 35, 423-443.
26. Oortwijn, W., Reuzel, R., Decker, M. (2004): Introduction to thematic issue on Ethical inquiry and (health) technology assessment: the social shaping perspective, Poiesis & Praxis 2, 97-101.
27. Pagon, R. A. (2002): Genetic testing for disease susceptibilities: consequences for genetic counselling, TRENDS in Molecular Medicine 8 (6), 306-307.
28. Palm, Elin and Hansson, Sven Ove (2006): The case for ethical technology assessment (eTA), Technological Forecasting and Social Change 73, 543-558.
29. Pot, J.H.J. van der (1985): Die Bewertung des technischen Fortschritts. Eine systematische Uebersicht der Theorien. Maastricht: Van Gorcum.
30. Reuzel, Rob et al. (2004): Ethics and HTA: some lessons and challenges for the future, Poiesis & Praxis 2, 247-256.
31. Rip, Arie, T.J. Misa, and J. Schot (eds.) (1995): Managing Technology in Society: The Approach of Constructive Technology Assessment. London/New York: Pinter.
32. Rip, Arie (2002): Challenges for Technology Foresight/Assessment and Governance. Final report of the STRATA consolidating workshop "Science and technology policies in Europe: new challenges, new responses". Brussels, 22-23 April 2002.
33. Roszek, B., Jong, W. H. de, and Geertsma, R. E., (2005): Nanotechnology in medical applications: state-of-the-art in materials and devices. Bilthoven: RijksInstituut voor Volksgezondheid en Milieuhygiëne.
34. Signaleringscommissie Kanker van KWF Kankerbestrijding (2007): Biomarkers en kanker. Amsterdam: KWF Kankerbestrijding.
35. Smadja, E.J. (2006): Scenario Planning as a Tool for Choosing more Ethical Futures: a Case Study in Nanoscale Science and Technology, Systems and Information Engineering Design Symposium, IEEE, 275-278.
36. Smit, Wim A. and Oost, Ellen J. van (1999): De wederzijdse beïnvloeding van technologie en maatschappij. Een Technology Assessment-benadering. Bussum: Countinho.
37. Stemerding, D. and Swierstra, T. (2006): How might interactive scenariostudies help us to think about the normative implications of genomics and predictive medicine, in A. de Bouvet, P. Boite and G. Aiguier (eds.), Questions ethiques en medicine predictive. Paris: John Libbey Eurotext.
38. Stemerding, D., Swierstra, T. and Boenink, M. (2010, in press): Exploring the interaction between technology and morality in the field of genetic susceptibility testing: a scenario study, Futures, doi:10.1016/j.futures.2009. 12.001.
39. Swierstra, Tsjalling (2004): Burger of slachtoffer? Een essay over het nader gebruik van lichaamsmateriaal ten behoeve van het genomics onderzoek. Pre-advies voor de Nederlandse vereniging voor Bio-ethiek. Amsterdam: NVBe.
40. Swierstra, Tsjalling, and Rip, Arie (2007): Nano-ethics as NEST-ethics: Patterns of Moral Argumentation About New and Emerging Science and Technology, Nanoethics 1, 3-20.
41. Swierstra, Tsjalling (2009): Willen we alles wat kan? Ethische controversen rondom wetenschap en technologie ontrafeld. Den Haag: ZonMw.
42. Swierstra, Tsjalling, Boenink, Marianne and Stemerding, Dirk (2009): Exploring Techno-Moral Change: The Case of the Obesity Pill, in Paul Sollie & Marcus Düwell (eds.), Evaluating New Technologies. Methodological Problems for the Ethical Assessment of Technology Developments. Dordrecht/Heidelberg: Springer, 119-138.
43. Swierstra, Tsjalling., van de Bovenkamp, Hester, Trappenburg, Margo (2010): Forging a fit between technology and morality. The Dutch debate on organ transplants, Technology in Society (32) 1, 55-64.
44. TA-Swiss (2003): Nanotechnologie in der Medizin, Kurzfassung. Bern: TA-Swiss Zentrum für Technologiefolgen-Abschätzung.
45. Trappenburg, Margo (2003): Darwin in de medische ethiek, in M. Adams, J. Griffiths and G.A. den Hartogh (eds.), Euthanasie. Nieuwe knelpunten in een voortgezette discussie. Kampen: Kok, 237-254.
46. TWA Netwerk (2006): Technologische innovaties in de (preventieve) gezondheidssector. Den Haag: Ministerie van Economische Zaken.
47. Valone, David A. (1998): The Changing Moral Landscape of Human Reproduction: Two Moments in the History of In Vitro Fertilization, The Mount Sinai Journal of Medicine, 65 (9), 167-172.
48. Veer, Laura van 't, et al. (2002): Gene expression profiling predicts clinical outcome of breast cancer, Nature 415, 530-535.
49. Vijver, Mark van den et al. (2002): A Gene-Expression Signature as a Predictor of Survival in Breast Cancer, New England Journal of Medicine 347 (25), 1999-2009.
50. Wagendorp, Bert (2007): Biologisch paspoort, de Volkskrant, October 24.
51. Williams, Robin (2008): Compressed Foresight and Narrative Bias: Pitfalls in Assessing High Technology Futures, in Erik Fisher, Cynthia Selin, Jameson M. Wetmore (eds.), The Yearbook of Nanotechnology in Society. Volume 1: Presenting Futures. Dordrecht: Springer, 265-289.
52. Wynne, Brian (2001): Creating Public Alienation: Expert Cultures of Risk and Ethics on GMOs, Science as Culture 10 (4), 445-481.